Amn Healthcare Financials
This page shows Amn Healthcare (AMN) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores
Amn Healthcare has an operating margin of -3.4%, meaning the company retains $-3 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is down from 8.9% the prior year.
Amn Healthcare's revenue declined 21.3% year-over-year, from $3.8B to $3.0B. This contraction results in a growth score of 0/100.
Amn Healthcare has a moderate D/E ratio of 1.49. This balance of debt and equity financing earns a leverage score of 56/100.
Amn Healthcare's current ratio of 1.09 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 24/100, which could limit financial flexibility.
Amn Healthcare has a free cash flow margin of 8.0%, earning a moderate score of 40/100. The company generates positive cash flow after capital investments, but with room for improvement.
Amn Healthcare passes 3 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Amn Healthcare generates $-2.18 in operating cash flow ($320.4M OCF vs -$147.0M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
Amn Healthcare earns $-1.5 in operating income for every $1 of interest expense (-$102.7M vs $69.9M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Amn Healthcare generated $3.0B in revenue in fiscal year 2024. This represents a decrease of 21.3% from the prior year.
Amn Healthcare's EBITDA was $71.1M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 85.8% from the prior year.
Amn Healthcare generated $239.5M in free cash flow in fiscal year 2024, representing cash available after capex. This represents a decrease of 10.8% from the prior year.
Amn Healthcare reported -$147.0M in net income in fiscal year 2024. This represents a decrease of 169.8% from the prior year.
Amn Healthcare earned $-3.85 per diluted share (EPS) in fiscal year 2024. This represents a decrease of 171.8% from the prior year.
Amn Healthcare held $10.6M in cash against $1.1B in long-term debt as of fiscal year 2024.
Amn Healthcare had 38M shares outstanding in fiscal year 2024. This represents an increase of 0.7% from the prior year.
Amn Healthcare's gross margin was 30.8% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is down 2.2 percentage points from the prior year.
Amn Healthcare's operating margin was -3.4% in fiscal year 2024, reflecting core business profitability. This is down 12.4 percentage points from the prior year.
Amn Healthcare's net profit margin was -4.9% in fiscal year 2024, showing the share of revenue converted to profit. This is down 10.5 percentage points from the prior year.
Amn Healthcare spent $0 on share buybacks in fiscal year 2024, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 100.0% from the prior year.
Amn Healthcare invested $80.9M in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 22.0% from the prior year.
AMN Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $634.5M-3.6% | $658.2M-4.5% | $689.5M-6.1% | $734.7M-0.8% | $740.7M-9.8% | $820.9M+0.3% | $818.3M-4.1% | $853.5M |
| Cost of Revenue | $450.1M-2.5% | $461.8M-6.0% | $491.4M-4.7% | $515.7M+1.0% | $510.9M-9.3% | $563.4M+1.1% | $557.3M-1.2% | $564.0M |
| Gross Profit | $184.4M-6.1% | $196.4M-0.9% | $198.1M-9.5% | $219.0M-4.7% | $229.8M-10.7% | $257.5M-1.3% | $260.9M-9.9% | $289.5M |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $138.6M-10.3% | $154.6M+4.6% | $147.7M-7.0% | $158.9M+6.6% | $149.0M-14.8% | $174.8M-5.7% | $185.5M+13.5% | $163.4M |
| Operating Income | $47.6M+138.5% | -$123.7M-1089.2% | $12.5M+106.2% | -$202.6M-637.5% | $37.7M-5.7% | $39.9M+16.9% | $34.2M-60.7% | $86.9M |
| Interest Expense | $9.6M-15.3% | $11.4M-7.8% | $12.3M-46.7% | $23.1M+47.1% | $15.7M-5.5% | $16.6M-17.5% | $20.2M+74.7% | $11.5M |
| Income Tax | $8.7M+146.1% | -$18.9M-1580.2% | $1.3M+103.3% | -$38.1M-765.5% | $5.7M-4.3% | $6.0M+295.1% | $1.5M-93.2% | $22.2M |
| Net Income | $29.3M+125.2% | -$116.2M-10541.2% | -$1.1M+99.4% | -$187.5M-1255.0% | $16.2M-6.3% | $17.3M+38.7% | $12.5M-76.5% | $53.2M |
| EPS (Diluted) | $0.76+125.2% | $-3.02-9966.7% | $-0.03+99.4% | $-4.90-1266.7% | $0.42-6.7% | $0.45+12.5% | $0.40-71.2% | $1.39 |
AMN Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.1B-3.3% | $2.2B-7.6% | $2.4B-0.9% | $2.4B-12.8% | $2.8B-3.6% | $2.9B-1.7% | $2.9B+10.2% | $2.7B |
| Current Assets | $570.3M-0.2% | $571.4M-8.9% | $627.4M+5.5% | $594.9M-15.6% | $704.8M-10.9% | $790.7M-6.1% | $841.7M+1.3% | $831.1M |
| Cash & Equivalents | $52.6M+26.8% | $41.5M-25.6% | $55.8M+423.8% | $10.6M-77.8% | $48.0M-5.0% | $50.6M+53.5% | $32.9M+12.1% | $29.4M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | $391.1M+0.9% | $387.8M-8.1% | $421.9M-3.6% | $437.8M-14.0% | $508.9M-12.1% | $578.6M-7.2% | $623.5M+10.2% | $565.7M |
| Goodwill | $755.8M0.0% | $755.8M-15.8% | $897.5M0.0% | $897.5M-19.6% | $1.1B+0.1% | $1.1B+0.3% | $1.1B+18.8% | $935.8M |
| Total Liabilities | $1.5B-6.9% | $1.6B-4.5% | $1.7B-1.7% | $1.7B-9.8% | $1.9B-6.2% | $2.0B-3.5% | $2.1B+13.9% | $1.8B |
| Current Liabilities | $542.2M-5.5% | $573.6M-1.5% | $582.2M+6.7% | $545.8M-4.9% | $573.9M-8.0% | $623.9M-4.9% | $656.1M-7.2% | $707.1M |
| Long-Term Debt | N/A | N/A | N/A | $1.1B | N/A | N/A | $1.3B | N/A |
| Total Equity | $644.4M+6.1% | $607.6M-15.0% | $715.1M+1.2% | $706.6M-19.4% | $876.9M+2.7% | $854.2M+2.8% | $831.3M+1.7% | $817.2M |
| Retained Earnings | $1.2B+2.5% | $1.2B-8.9% | $1.3B-0.1% | $1.3B-12.2% | $1.5B+1.1% | $1.5B+1.2% | $1.5B+0.9% | $1.4B |
AMN Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $22.7M-71.1% | $78.5M-15.2% | $92.7M+27.3% | $72.8M-26.8% | $99.5M+22.3% | $81.4M+297.9% | -$41.1M-123.9% | $172.2M |
| Capital Expenditures | $7.9M-19.3% | $9.8M-1.8% | $10.0M-38.5% | $16.2M-40.5% | $27.3M+50.3% | $18.1M-39.2% | $29.9M-0.1% | $29.9M |
| Free Cash Flow | $14.8M-78.5% | $68.7M-16.9% | $82.7M+46.1% | $56.6M-21.7% | $72.2M+14.2% | $63.2M+189.1% | -$71.0M-149.9% | $142.3M |
| Investing Cash Flow | $59.0M+386.5% | -$20.6M+20.9% | -$26.0M-83.4% | -$14.2M+36.4% | -$22.3M-4.4% | -$21.4M+93.4% | -$323.7M-854.9% | -$33.9M |
| Financing Cash Flow | -$71.2M+11.2% | -$80.2M-31.1% | -$61.2M+23.4% | -$79.9M+0.3% | -$80.1M-105.5% | -$39.0M-110.7% | $363.5M+446.1% | -$105.0M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | $0 | $0 | $0 | $0 | $0 |
AMN Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 29.1%-0.8pp | 29.8%+1.1pp | 28.7%-1.1pp | 29.8%-1.2pp | 31.0%-0.3pp | 31.4%-0.5pp | 31.9%-2.0pp | 33.9% |
| Operating Margin | 7.5%+26.3pp | -18.8%-20.6pp | 1.8%+29.4pp | -27.6%-32.7pp | 5.1%+0.2pp | 4.9%+0.7pp | 4.2%-6.0pp | 10.2% |
| Net Margin | 4.6%+22.3pp | -17.7%-17.5pp | -0.2%+25.4pp | -25.5%-27.7pp | 2.2%+0.1pp | 2.1%+0.6pp | 1.5%-4.7pp | 6.2% |
| Return on Equity | 4.5% | N/A | N/A | 0.8%-1.1pp | 1.8%-0.2pp | 2.0%+0.5pp | 1.5%-5.0pp | 6.5% |
| Return on Assets | 1.4%+6.6pp | -5.3%-5.2pp | -0.1%+7.7pp | -7.8%-8.3pp | 0.6%-0.0pp | 0.6%+0.2pp | 0.4%-1.6pp | 2.0% |
| Current Ratio | 1.05+0.1 | 1.00-0.1 | 1.08-0.0 | 1.09-0.1 | 1.23-0.0 | 1.27-0.0 | 1.28+0.1 | 1.18 |
| Debt-to-Equity | 2.32-0.3 | 2.64+0.3 | 2.35+0.9 | 1.49-0.7 | 2.16-0.2 | 2.36+0.8 | 1.57-0.7 | 2.25 |
| FCF Margin | 2.3%-8.1pp | 10.4%-1.5pp | 12.0%+4.3pp | 7.7%-2.1pp | 9.8%+2.1pp | 7.7%+16.4pp | -8.7%-25.4pp | 16.7% |
Similar Companies
Frequently Asked Questions
What is Amn Healthcare's annual revenue?
Amn Healthcare (AMN) reported $3.0B in total revenue for fiscal year 2024. This represents a -21.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Amn Healthcare's revenue growing?
Amn Healthcare (AMN) revenue declined by 21.3% year-over-year, from $3.8B to $3.0B in fiscal year 2024.
Is Amn Healthcare profitable?
No, Amn Healthcare (AMN) reported a net income of -$147.0M in fiscal year 2024, with a net profit margin of -4.9%.
What is Amn Healthcare's earnings per share (EPS)?
Amn Healthcare (AMN) reported diluted earnings per share of $-3.85 for fiscal year 2024. This represents a -171.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Amn Healthcare's EBITDA?
Amn Healthcare (AMN) had EBITDA of $71.1M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Amn Healthcare have?
As of fiscal year 2024, Amn Healthcare (AMN) had $10.6M in cash and equivalents against $1.1B in long-term debt.
What is Amn Healthcare's gross margin?
Amn Healthcare (AMN) had a gross margin of 30.8% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.
What is Amn Healthcare's operating margin?
Amn Healthcare (AMN) had an operating margin of -3.4% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is Amn Healthcare's net profit margin?
Amn Healthcare (AMN) had a net profit margin of -4.9% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
What is Amn Healthcare's free cash flow?
Amn Healthcare (AMN) generated $239.5M in free cash flow during fiscal year 2024. This represents a -10.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Amn Healthcare's operating cash flow?
Amn Healthcare (AMN) generated $320.4M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Amn Healthcare's total assets?
Amn Healthcare (AMN) had $2.4B in total assets as of fiscal year 2024, including both current and long-term assets.
What are Amn Healthcare's capital expenditures?
Amn Healthcare (AMN) invested $80.9M in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.
How many shares does Amn Healthcare have outstanding?
Amn Healthcare (AMN) had 38M shares outstanding as of fiscal year 2024.
What is Amn Healthcare's current ratio?
Amn Healthcare (AMN) had a current ratio of 1.09 as of fiscal year 2024, which is considered adequate.
What is Amn Healthcare's debt-to-equity ratio?
Amn Healthcare (AMN) had a debt-to-equity ratio of 1.49 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Amn Healthcare's return on assets (ROA)?
Amn Healthcare (AMN) had a return on assets of -6.1% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Amn Healthcare's Piotroski F-Score?
Amn Healthcare (AMN) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Amn Healthcare's earnings high quality?
Amn Healthcare (AMN) has an earnings quality ratio of -2.18x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Amn Healthcare cover its interest payments?
Amn Healthcare (AMN) has an interest coverage ratio of -1.5x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Amn Healthcare?
Amn Healthcare (AMN) scores 24 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.